Episode 74
Biotech Hangout
00:00
Biotech's Business Model and Profitability Challenges
The speakers analyze the business model of disruptive technologies in biotech, the challenges of profitability in today's market, and the trends in M&A within the industry. They discuss the decline of the XBI index and the reasons behind it, highlighting the positive developments despite its performance. The chapter also touches on financing deals in the industry and the importance of finding fundamentally good assets.
Transcript
Play full episode
